We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) to Post Q1 Earnings: What's in Store?
Read MoreHide Full Article
Tenet Healthcare Corporation (THC - Free Report) will report first-quarter 2019 results on Apr 29 after market close. In the last reported quarter, the company delivered a positive surprise of 112.5%. However, the bottom line plunged 63.6% year over year, mainly due to weak operating revenues.
Let’s see how things are shaping up prior to this announcement:
In the to-be-reported quarter, the company’s performance is likely to suffer a decline in revenues due to reduced admissions, inpatient and outpatient surgeries, emergency department visits and total outpatient visits.
Weak performances by its segments, namely Conifer and Hospital operations plus other segments might also negatively impact its revenue stream. Conifer’s bottom line is likely to be hurt by hospital divestitures.
The Zacks Consensus Estimate for the company’s total revenues in the to-be reported quarter stands at $4.5 billion, indicating 40.6% fall from the year-ago reported figure.
The Zacks Consensus Estimate for the stock’s earnings is pegged at 30 cents, suggesting 47.4% decrease from the prior-year reported number. The metric is likely to be affected in the upcoming quarterly results due to lower revenues.
However, overdependence on debt to fund the growth-related investments raises the financial risk for Tenet Healthcare.
What the Quantitative Model States
Our proven model does not conclusively show that Tenet Healthcare is likely to beat on earnings this to-be-reported quarter. This is because the stock has the right combination of a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen, which is not the case here.
Earnings ESP: Tenet Healthcare has an Earnings ESP of -10.89%. This is because the Most Accurate Estimate is pegged at 27 cents, lower than the Zacks Consensus Estimate of 30 cents. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Tenet Healthcare Corporation Price and EPS Surprise
Zacks Rank: Tenet Healthcare carries a Zacks Rank #2, which increases the predictive power of ESP. However, the company’s negative ESP in the combination leaves surprise prediction inconclusive for the stock this reporting cycle.
We caution against Sell-rated stocks (#4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Some stocks worth considering from the medical sector with the perfect combination of elements to surpass estimates in the next releases are as follows:
bluebird bio, Inc. (BLUE - Free Report) has an Earnings ESP of +12.12%. This #3 Ranked company is set to report third-quarter earnings on May 1.
Humana Inc. (HUM - Free Report) is set to report first-quarter 2018 earnings performance on May 1. The stock has an Earnings ESP of +0.84% and a Zacks Rank of 3.
Radical New Technology Creates $12.3 Trillion Opportunity
Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.
Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
Image: Bigstock
Tenet Healthcare (THC) to Post Q1 Earnings: What's in Store?
Tenet Healthcare Corporation (THC - Free Report) will report first-quarter 2019 results on Apr 29 after market close. In the last reported quarter, the company delivered a positive surprise of 112.5%. However, the bottom line plunged 63.6% year over year, mainly due to weak operating revenues.
Let’s see how things are shaping up prior to this announcement:
In the to-be-reported quarter, the company’s performance is likely to suffer a decline in revenues due to reduced admissions, inpatient and outpatient surgeries, emergency department visits and total outpatient visits.
Weak performances by its segments, namely Conifer and Hospital operations plus other segments might also negatively impact its revenue stream. Conifer’s bottom line is likely to be hurt by hospital divestitures.
The Zacks Consensus Estimate for the company’s total revenues in the to-be reported quarter stands at $4.5 billion, indicating 40.6% fall from the year-ago reported figure.
The Zacks Consensus Estimate for the stock’s earnings is pegged at 30 cents, suggesting 47.4% decrease from the prior-year reported number. The metric is likely to be affected in the upcoming quarterly results due to lower revenues.
However, overdependence on debt to fund the growth-related investments raises the financial risk for Tenet Healthcare.
What the Quantitative Model States
Our proven model does not conclusively show that Tenet Healthcare is likely to beat on earnings this to-be-reported quarter. This is because the stock has the right combination of a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen, which is not the case here.
Earnings ESP: Tenet Healthcare has an Earnings ESP of -10.89%. This is because the Most Accurate Estimate is pegged at 27 cents, lower than the Zacks Consensus Estimate of 30 cents. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Tenet Healthcare Corporation Price and EPS Surprise
Tenet Healthcare Corporation Price and EPS Surprise | Tenet Healthcare Corporation Quote
Zacks Rank: Tenet Healthcare carries a Zacks Rank #2, which increases the predictive power of ESP. However, the company’s negative ESP in the combination leaves surprise prediction inconclusive for the stock this reporting cycle.
We caution against Sell-rated stocks (#4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Some stocks worth considering from the medical sector with the perfect combination of elements to surpass estimates in the next releases are as follows:
Aduro Biotech, Inc. is slated to release third-quarter earnings figures on May 1. This stock has an Earnings ESP of +82.00% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
bluebird bio, Inc. (BLUE - Free Report) has an Earnings ESP of +12.12%. This #3 Ranked company is set to report third-quarter earnings on May 1.
Humana Inc. (HUM - Free Report) is set to report first-quarter 2018 earnings performance on May 1. The stock has an Earnings ESP of +0.84% and a Zacks Rank of 3.
Radical New Technology Creates $12.3 Trillion Opportunity
Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.
Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
See the 7 breakthrough stocks now>>